Final Concept Paper M4E(R2): Enhancing the Format and Structure of Benefit-Risk Information in ICH M4E(R1) Guideline Revised on 23 March 2015 Endorsed by the ICH Steering Committee on 27 March 2015

First Page		Document Content
Date: 2015-04-14 09:36:09 Pharmaceuticals policy Management Safety Actuarial science Ethics Environmental Working Group Risk Clinical research Drug safety International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use		Final Concept Paper M4E(R2): Enhancing the Format and Structure of Benefit-Risk Information in ICH M4E(R1) Guideline Revised on 23 March 2015 Endorsed by the ICH Steering Committee on 27 March 2015 Add to Reading List Source URL: www.ich.org Download Document from Source Website File Size: 185,96 KB Share Document on Facebook

	The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis DocID: 1vrwY - View Document
	Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather DocID: 1vpIt - View Document
	Clinical Research Registration at Public Registry DocID: 1vnxr - View Document
	Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im DocID: 1vi9N - View Document
	Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location DocID: 1vglz - View Document